Clinical Trials Browser

Melanoma × MAPRE1 protein, human × 90 days × Clear all

NCT06216938 2026-04-13

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

Phase EARLY_PHASE1 Recruiting

Melanoma